Invention Grant
- Patent Title: N1-pyrazolospiroketone acetyl-CoA carboxylase inhibitors
- Patent Title (中): N-吡唑啉酮酮乙酰辅酶A羧化酶抑制剂
-
Application No.: US14491016Application Date: 2014-09-19
-
Publication No.: US09145416B2Publication Date: 2015-09-29
- Inventor: Mary Theresa Didiuk , Robert Lee Dow , David Andrew Griffith
- Applicant: Pfizer Inc.
- Applicant Address: US NY New York
- Assignee: Pfizer Inc.
- Current Assignee: Pfizer Inc.
- Current Assignee Address: US NY New York
- Agent James T. Wasicak
- Main IPC: A61K31/44
- IPC: A61K31/44 ; C07D471/10 ; C07D491/20 ; C07D519/00 ; A61K31/438 ; A61K31/519 ; A61K45/06 ; C07D487/10 ; A61K31/435
Abstract:
The invention provides a compound of Formula (I) or a pharmaceutically acceptable salt of the compound, wherein R1, R2, R3, Z, A1, L and A2 are as described herein; pharmaceutical compositions thereof; and the use thereof in treating diseases, conditions or disorders modulated by the inhibition of an acetyl-CoA carboxylase enzyme(s) in an animal.
Public/Granted literature
- US20150011470A1 N1-PYRAZOLOSPIROKETONE ACETYL-CoA CARBOXYLASE INHIBITORS Public/Granted day:2015-01-08
Information query
